Plan panel sets $100-bn target for pharma sector

Image
Press Trust Of India New Delhi
Last Updated : Dec 26 2012 | 12:00 AM IST

The Planning Commission has set a target for the pharmaceutical industry to reach $100 billion by 2020 and account for five per cent share of the global drug industry in the next five years. According to the final draft of the 12th Five-Year Plan (2012-17) by the panel, the objective of the sector will be to cross the $60-billion mark in 2017, which will be five per cent of the global pharma industry.

The Indian pharmaceutical industry is valued at $22 billion, and is the third largest in terms of volume and 13th in terms of value globally.

According to the draft plan, the exports of pharma-products should rise to Rs 1.3 lakh crore by the end of the 12th Five Year Plan. “The sector should employ 1.5 million people by 2015, 1.9 million by 2018 and 2.4 million people by 2022,” it added.

According to the draft plan, which will be submitted to the National Development Council (NDC) tomorrow, all the Central public sector undertakings (CPSUs) involved in production of pharmaceutical products should be self-sustaining by 2020.

In order to achieve the target, the Planning Commission has recommended various steps which include capacity building of private sector to meet WHO-GMP (World Health Organization-Good Manufacturing Practice) standards and other international manufacturing requirements.

The other recommendations include developing a common infrastructure in drug discovery and development such as manufacturing, distribution, exports and medical devices.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 26 2012 | 12:00 AM IST

Next Story